Boston Scientific Reaches $38.5M Deal To End Investor Suit
Investors suing Boston Scientific Inc. for touting a heart valve product that was later pulled from the market announced Friday that they have settled their stock suit against the medical device...To view the full article, register now.
Already a subscriber? Click here to view full article